Skip to main content
. 2019 May 13;30(6):1096–1108. doi: 10.1681/ASN.2018101058

Figure 2.

Figure 2.

Changes in serum phosphate and FGF23 over 12 months in response to nicotinamide and lanthanum carbonate in nondialysis CKD. (A) Changes in serum phosphate by treatment arm in the COMBINE trial are presented as means with error bars reflecting ±1 SD. (B) Changes in intact FGF23 (B) by treatment arm are presented as medians; error bars depict interquartile ranges. N-L, nicotinamide active/lanthanum carbonate active; N-p, nicotinamide active/lanthanum carbonate placebo; p-L, nicotinamide placebo/lanthanum carbonate active; p-p, nicotinamide placebo/lanthanum carbonate placebo.